His scientific interests lie mostly in Cancer research, Apoptosis, Pharmacology, In vivo and Navitoclax. His studies deal with areas such as Cell culture, Survivin, Immunology, Cell cycle and Regulation of gene expression as well as Cancer research. His Apoptosis study contributes to a more complete understanding of Biochemistry.

His In vivo research includes themes of Platelet and Paclitaxel. His work carried out in the field of Navitoclax brings together such families of science as Venetoclax, Survival analysis, Leukemia and Neutropenia. Saul H. Rosenberg has included themes like Oral administration and Obatoclax in his BH3 Mimetic ABT-737 study.